Grouping cost analysis for FAP (APC and MUTYH genes) and HNPCC (MLH1, MSH2 and MSH6 genes) syndromes, NGS analysis integrated by Sanger sequencing results significantly cheaper in comparison to Sanger sequencing alone for both types of probands (Table 3). This evidence concerns the gene MLH1 and hereditary nonpolyposis colon cancer.